Factors associated with early insulin initiation in Type 2 diabetes: a Canadian cross-sectional study

Diabetic Medicine

Volumn 34, Issue 2, 2017, Pages 229-234

  Abu Ashour, W ^a   Chibrikova, L ^a   Midodzi, W K ^a   Twells, L K ^a   Gamble, J M ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANADIAN; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; UNDERWEIGHT; AGE; CANADA; DRINKING BEHAVIOR; EARLY INTERVENTION; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTOR; SEX FACTOR; SMOKING; STATISTICAL MODEL; TIME FACTOR;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; CANADA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EARLY MEDICAL INTERVENTION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LOGISTIC MODELS; MALE; MENTAL HEALTH; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OVERWEIGHT; RISK FACTORS; SEX FACTORS; SMOKING; TIME FACTORS;

EID: 84959105986     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13082     Document Type: Article

References (21)

1. UK Prospective Diabetes Study. 16. Overview of 6 years therapy of type II diabetes: a progressive disease. UK prospective diabetes study group. Diabetes 1995; 44: 1249–1258.
2. Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M et al. Management of Hyperglycemia in Type2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35: 1364–1370.
3. Harper W, Clement M, Goldenberg R, Hanna A, Main A, Retnakaran R et al. Clinical Practice Guidelines: Pharmacologic Management of Type 2 Diabetes Canadian Diabetes Association Clinical Practice Guidelines Expert Committee Can J. Diabetes 2013; 37: S61–S68.
4. Gerstein H, Rosenstock J. Insulin therapy in people who have dysglycemia and type 2 diabetes mellitus: can it offer both cardiovascular protection and beta-cell preservation? Endocrinol Metab Clin North Am 2005; 34: 137–154.
5. Chiasson JL. Early insulin use in type 2 diabetes. What are the cons? Diabetes Care 2009; 32: 270–274.
6. Lebovitz H, Dole JO, Patwardhan R, Rappaport E, Freed M. Rosiglitazone Clinical Trials Study Group Rosiglitazone monotherapy is efeective in patients with type 2 diabetes. J Clin Endocrinol Metab 2001; 86: 280–288.
7. Holden S, Gale E, Jenkins-Jones S, Currie C. How many people inject insulin? UK estimates from 1991 to 2010. Diabetes Obes Metab 2014; 16: 553–559.
8. Lipska K, Ross J, Van Houten H, Beran D, Yudkin J, Shah N. Use an out of pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010. JAMA 2014; 311: 2331–2333.
9. Reach G, Le Pautremat V, Gupta S. Determinants and consequences of insulin initiation for type 2 diabetes in France: analysis of the national health and wellness survey. Patient Prefer Adherence 2013; 7: 1007–1023.
10. Grant R, Adams A, Trinacty C, Zhang F, Kleinman K, Soumerai S, et al. Relationship between patient adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care 2007; 30: 807–812.
11. Conner M, Norman P. Predicting health behavior: a social cognition approach. In: Conner M, Norman P eds. Predicting health behaviours. New York, NY: Open University Press, 2005: 1–27.
12. Harvey J, Lawson V. The importance of health belief models in determining self-care behaviors. Diabet Med 2009; 26: 5–13.
13. Davies M, Gagliardino J, Gray L, Khunti K, Mohan V, Hughes R. Real world factors affecting adherence to insulin therapy in patients with type 1 or type 2 diabetes mellitus: a systematic review. Diabet Med 2013; 30: 512–524.
14. Yeung R, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon KH et al. Metabolic profiles and treatment gaps in young onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol 2014; 2: 935–943.
15. Browne J, Ventura A, Mosely K, Speight J. I call it the blame and shame disease: a qualitative study about perceptions of social stigma surrounding type 2 diabetes. BMJ Open 2013; 3: e003384.
16. Morgan S, Smolina K, Mooney D, Raymond C, Bowen M, Gorczynski C et al. The Canadian Rx Atlas, 3rd ed. Vancouver: Centre for Health Services and Policy Research, University of British Columbia, 2013.
17. Rim E, Chan J, Stampfer M, Colditz G, Willet W. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ 1995; 310: 555–559.
18. Facchini F, Chen Y-DI, Reaven GM. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care 1994; 17: 115–119.
19. Health Canada. Diabetes in Canada: national statistics and opportunities for improved surveillance, prevention and control. Ottwa: Minister of public works and government services; Report No:H49-121/1999.
20. Zinnman B, Khan S, Haffner S, O'Neil M, Heise M, Freed M. Phenotypic characteristics of gad antibody–positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 2004; 53: 3193–3200.
21. Statistics Canada. Canadian Community Health Survey (CCHS) Annual Component. User guide 2012 and 2011-2012 Microdata Files. Available at www.statcan.gc.ca Last accessed 14 November 2015.